Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Sanofi-Aventis to Pony Up $4B for Merck & Co.’s Half of the Firms’ Animal Health JV

Sanofi-Aventis has a call-option agreement to merge Merial with Intervet/Schering-Plough after Merck closes its acquisition of Schering-Plough.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »